SCHEMBL935320

SCHEMBL935320

[CH2]OCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3502089 0.82
SCHEMBL2468575 0.77
SCHEMBL7704408 0.77
SCHEMBL7319163 0.74
SCHEMBL55912 0.73
SCHEMBL4512521 0.71
SCHEMBL23765660 0.70 MEN1 (0.38)
SCHEMBL19107454 0.70 MEN1 (0.38)
SCHEMBL454356 0.70 MEN1 (0.38)
SCHEMBL2639323 0.70 MEN1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411468-A1 PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII HOFFMANN-LA ROCHE INC. (US) 2022-12-29 US claimed
US-10968198-B2 Biaryltriazole inhibitors of macrophage migration inhibitory factor YALE UNIVERSITY (US) 2021-04-06 US claimed
EP-3267794-B1 BIARYLTRIAZOLE INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR UNIV YALE (US) 2020-09-09 EP claimed
EP-3368544-B1 PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII HOFFMANN LA ROCHE (CH) 2020-06-17 EP claimed
US-20190276425-A1 BIARYLTRIAZOLE INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR UNIV YALE (US) 2019-09-12 US claimed
US-10336721-B2 Biaryltriazole inhibitors of macrophage migration inhibitory factor YALE UNIVERSITY (US) 2019-07-02 US claimed
EP-3368544-A1 PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII H. Hoffnabb-La Roche Ag (CH) 2018-09-05 EP claimed
CN-108350028-A PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII 豪夫迈·罗氏有限公司 2018-07-31 CN claimed
US-10030047-B2 Peptide macrocycles against acinetobacter baumannii HOFFMANN-LA ROCHE INC. (US) 2018-07-24 US claimed
US-20180179176-A1 BIARYLTRIAZOLE INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR UNIV YALE (US) 2018-06-28 US claimed
WO-2000059881-A1 SUBSTITUTED AZETIDIN-2-ONES AS CYSTEINE PROTEASE INHIBITORS NAEJA PHARMACEUTICAL INC (CA) 2000-10-12 WO claimed
WO-2000047560-A2 PROCESS FOR THE PREPARATION OF ASYMMETRICAL 1,4-DIHYDRO-PYRIDINE-DICARBOXYLIC ACID ESTERS EGIS Gyógyszergyár Rt. (HU) 2000-08-17 WO claimed
US-5606066-A Light activable \"caged\" 1-(2-nitrobenzyl)-substituted 1,4-dihydropyridines GOLDMANN SIEGFRIED (DE) 1997-02-25 US claimed
EP-0533504-B1 Dihydropyridine derivatives useful in antitumor therapy PHARMACIA & UPJOHN SPA (IT) 1997-02-05 EP claimed
EP-0566142-A1 Inclusion complexes of optically active and racemic 1,4-dihydro pyridines with cyclodextrin derivates LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. (SI) 1993-10-20 EP claimed
EP-0533504-A1 Dihydropyridine derivatives useful in antitumor therapy PHARMACIA S.p.A. (IT) 1993-03-24 EP claimed
EP-0234517-A1 Pyrrolo[3,4-b]pyridines, process for their preparation and medicaments containing them for the treatment of vascular diseases GÖDECKE AKTIENGESELLSCHAFT (DE) 1987-09-02 EP claimed
EP-0225175-A2 Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof FISONS plc (GB) 1987-06-10 EP claimed
CN-85106878-A The method for preparing compound 1986-07-23 CN claimed
EP-0174131-A2 Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them FISONS plc (GB) 1986-03-12 EP claimed